Three years survival outcome and continued cemiplimab (CEMI) beyond progression with the addition of chemotherapy (chemo) for patients (pts) with advanced non-small cell lung cancer (NSCLC): The EMPOWER-Lung 1 trial

Creative Commons License

Ozguroglu M., Kilickap S., Sezer A., Gumus M., Bondarenko I., Gogishvili M., ...More

ANNALS OF ONCOLOGY, vol.33, no.7, 2022 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Volume: 33 Issue: 7
  • Publication Date: 2022
  • Doi Number: 10.1016/j.annonc.2022.08.056
  • Journal Name: ANNALS OF ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University-Cerrahpasa Affiliated: No